nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—MAOA—Clearance of dopamine—SLC6A3—Gilles de la Tourette syndrome	0.15	0.151	CbGpPWpGaD
Phenylephrine—MAOA—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.119	0.119	CbGpPWpGaD
Phenylephrine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0683	0.0687	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0273	0.0275	CbGpPWpGaD
Phenylephrine—ADRA1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0233	0.0234	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0227	0.0228	CbGpPWpGaD
Phenylephrine—ADRA1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0226	0.0228	CbGpPWpGaD
Phenylephrine—ADRA1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0211	0.0212	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0201	0.0203	CbGpPWpGaD
Phenylephrine—ADRA1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0196	0.0197	CbGpPWpGaD
Phenylephrine—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0193	0.0195	CbGpPWpGaD
Phenylephrine—ADRA1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.019	0.0191	CbGpPWpGaD
Phenylephrine—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0188	0.0189	CbGpPWpGaD
Phenylephrine—ADRA1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0177	0.0178	CbGpPWpGaD
Phenylephrine—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0175	0.0176	CbGpPWpGaD
Phenylephrine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0172	0.0173	CbGpPWpGaD
Phenylephrine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0167	0.0168	CbGpPWpGaD
Phenylephrine—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0162	0.0164	CbGpPWpGaD
Phenylephrine—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0158	0.0159	CbGpPWpGaD
Phenylephrine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0155	0.0156	CbGpPWpGaD
Phenylephrine—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0147	0.0149	CbGpPWpGaD
Phenylephrine—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0147	0.0148	CbGpPWpGaD
Phenylephrine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0144	0.0145	CbGpPWpGaD
Phenylephrine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.014	0.0141	CbGpPWpGaD
Phenylephrine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.013	0.0131	CbGpPWpGaD
Phenylephrine—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0124	0.0125	CbGpPWpGaD
Phenylephrine—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0122	0.0123	CbGpPWpGaD
Phenylephrine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0109	0.011	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0103	0.0104	CbGpPWpGaD
Phenylephrine—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0103	0.0104	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.01	0.0101	CbGpPWpGaD
Phenylephrine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00914	0.0092	CbGpPWpGaD
Phenylephrine—Norepinephrine—DRD2—Gilles de la Tourette syndrome	0.0071	1	CrCbGaD
Phenylephrine—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00655	0.0066	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0052	0.00523	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00449	0.00453	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00436	0.0044	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00436	0.00439	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00406	0.00409	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00398	0.00401	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00385	0.00388	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00374	0.00376	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00373	0.00376	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00368	0.00371	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00362	0.00365	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00348	0.00351	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00337	0.0034	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00331	0.00334	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00329	0.00332	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00322	0.00324	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0032	0.00322	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0031	0.00312	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00306	0.00308	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.003	0.00302	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00293	0.00295	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00289	0.00291	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HDC—Gilles de la Tourette syndrome	0.00288	0.0029	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00285	0.00287	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00285	0.00287	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00284	0.00286	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00276	0.00277	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00273	0.00275	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00271	0.00273	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00265	0.00267	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00257	0.00259	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00244	0.00246	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00243	0.00245	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00243	0.00245	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00236	0.00238	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00236	0.00238	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0022	0.00222	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00216	0.00218	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0021	0.00211	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0021	0.00211	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00202	0.00204	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00195	0.00197	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00186	0.00187	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0018	0.00181	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00166	0.00167	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00161	0.00162	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00154	0.00155	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0015	0.00152	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0015	0.00151	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00146	0.00147	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00138	0.00138	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00137	0.00138	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00136	0.00137	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00133	0.00134	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00125	0.00126	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00124	0.00125	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00122	0.00123	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00121	0.00122	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00113	0.00114	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00111	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0011	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00108	0.00108	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00106	0.00107	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00106	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.001	0.00101	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000953	0.00096	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000889	0.000895	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000871	0.000877	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000863	0.000869	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000804	0.000809	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000791	0.000797	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000774	0.000779	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000738	0.000743	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000716	0.000721	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000703	0.000708	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000667	0.000672	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000655	0.00066	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000636	0.000641	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000593	0.000597	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000563	0.000567	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000467	0.000471	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000415	0.000418	CbGpPWpGaD
